Journal profile · Pharmacology & Pharmacy
Critical Reviews in Therapeutic Drug Carrier Systems
ISSN 0743-4863 · eISSN 2162-660X · Begell House Inc. · UNITED STATES · Bimonthly · Founded 1984
Critical Reviews in Therapeutic Drug Carrier Systems: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.4; subscription journal; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 28 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Critical Reviews in Therapeutic Drug Carrier Systems is published by Begell House Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Nanoparticle-Based Drug Delivery and Drug Solubulity and Delivery Systems, together about 40.6% of its articles. Its main subfields are Pharmaceutical Science and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields. Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics16.8%
- Nanoparticle-Based Drug DeliveryMaterials Science12.3%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics11.5%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology11.5%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics7%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology4.6%
- Lipid Membrane Structure and BehaviorBiochemistry, Genetics and Molecular Biology4.3%
- Inhalation and Respiratory Drug DeliveryMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.4LetPub ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 0.47LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 69LetPub ·
- h-index
- 88OpenAlex ·
- i10-index
- 335OpenAlex ·
- 2-year mean citedness
- 2OpenAlex ·
- Self-citation rate
- 16%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 18LetPub ·
Articles by year OpenAlex count · 620 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 0 | 1 |
| 2025 | 28 | 1 | 39 |
| 2024 | 17 | 1 | 74 |
| 2023 | 25 | 2 | 115 |
| 2022 | 29 | 3 | 256 |
| 2021 | 29 | 6 | 351 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Begell House Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1984
- ISSN
- 0743-4863
- Electronic ISSN
- 2162-660X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Critical Reviews in Therapeutic Drug Carrier Systems
What CAS zone is Critical Reviews in Therapeutic Drug Carrier Systems in?
In the 2025 upgraded edition of the CAS Journal Ranking, Critical Reviews in Therapeutic Drug Carrier Systems is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Critical Reviews in Therapeutic Drug Carrier Systems?
The latest impact factor listed by LetPub is 2.4; CiteScore 6, h-index 88.
How long does peer review take at Critical Reviews in Therapeutic Drug Carrier Systems?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Critical Reviews in Therapeutic Drug Carrier Systems?
According to LetPub and DOAJ records, Critical Reviews in Therapeutic Drug Carrier Systems is indexed in SCIE and Scopus.
Is Critical Reviews in Therapeutic Drug Carrier Systems open access, and what is the APC?
Critical Reviews in Therapeutic Drug Carrier Systems is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .